Screener / SEC EDGAR /CIK 0000885590 /10-K filed Feb 19, 2026, compared with Feb 20, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Pharmaceuticals

Bausch Health Companies Inc. BHC

Compare with peers Embed

BHC among the 162 companies we cover

Where it stands · the better end on the right. The band holds the middle half; the line is the median.

All 162
Sales growth
+4.8%+20.2%
+6.7%103rd of 155 · median +10.5%
Net margin
-4.1%15.3%
-7.6%123rd of 154 · median 6.8%
Free cash flow margin
2.3%19.2%
16.8%44th of 145 · median 10.0%

BHC and 9 peers, year by year

The 9 Health care companies closest to BHC in revenue over the last twelve months. Every number is from the 10-K and links to it in SEC's Inline XBRL viewer.

Choose the peers

Health care companies (up to 9):

Each company's latest fiscal year
CompanyYearRevenueSales growthGross marginOperating marginNet marginFCF marginReturn on equityDebt / equity
BHC Bausch Health Companies Inc. FY2025 $10.3B+6.7%-17.7%1.5%9.8%n/mn/m
ISRG Intuitive Surgical FY2025 $10.1B+20.5%66.0%29.3%28.4%24.7%16.0%-
BAX Baxter International FY2025 $11.2B+5.7%30.1%−2.7%−8.5%3.0%−15.6%1.54
DGX Quest Diagnostics FY2025 $11.0B+11.8%-14.1%9.0%12.3%13.8%0.79
BIIB Biogen FY2025 $9.9B+2.2%--13.1%20.7%7.1%0.34
ZTS Zoetis FY2025 $9.5B+2.3%--28.2%24.1%78.3%2.65
VRTX Vertex Pharmaceuticals FY2025 $12.0B+8.9%-34.8%32.9%26.6%21.2%0.00
ZBH Zimmer Biomet FY2025 $8.2B+7.2%-13.3%8.6%17.9%5.6%0.59
HSIC Henry Schein FY2025 $13.2B+4.0%31.1%5.0%3.0%4.3%12.3%0.96
SOLV Solventum FY2025 $8.3B+0.9%53.5%26.2%18.7%−0.1%30.8%1.00

Each company, year by year

Bars: revenue, each company on its own scale. Line: net margin, on one scale for all. FY2016 to FY2025 · 10-K XBRL

BHCBausch Health Companies Inc.
FY2016 revenue $9.7BFY2017 revenue $8.7BFY2018 revenue $8.4BFY2019 revenue $8.6BFY2020 revenue $8.0BFY2021 revenue $8.4BFY2022 revenue $8.1BFY2023 revenue $8.8BFY2024 revenue $9.6BFY2025 revenue $10.3B FY2016 net margin −24.9%FY2017 net margin 27.6%FY2018 net margin −49.5%FY2019 net margin −20.8%FY2020 net margin −7.0%FY2021 net margin −11.2%FY2022 net margin −2.8%FY2023 net margin −6.8%FY2024 net margin −0.5%FY2025 net margin 1.5% FY2016FY2025
Revenue$10.3B Growth+6.7% Net margin1.5%
ISRGIntuitive Surgical
FY2016 revenue $2.7BFY2017 revenue $3.1BFY2018 revenue $3.7BFY2019 revenue $4.5BFY2020 revenue $4.4BFY2021 revenue $5.7BFY2022 revenue $6.2BFY2023 revenue $7.1BFY2024 revenue $8.4BFY2025 revenue $10.1B FY2016 net margin 27.3%FY2017 net margin 21.4%FY2018 net margin 30.3%FY2019 net margin 30.8%FY2020 net margin 24.3%FY2021 net margin 29.9%FY2022 net margin 21.3%FY2023 net margin 25.2%FY2024 net margin 27.8%FY2025 net margin 28.4% FY2016FY2025
Revenue$10.1B Growth+20.5% Net margin28.4%
BAXBaxter International
FY2016 revenue $10.2BFY2017 revenue $10.6BFY2018 revenue $11.1BFY2019 revenue $11.4BFY2020 revenue $11.7BFY2021 revenue $12.1BFY2022 revenue $10.1BFY2023 revenue $10.4BFY2024 revenue $10.6BFY2025 revenue $11.2B FY2016 net margin 48.9%FY2017 net margin 5.7%FY2018 net margin 13.9%FY2019 net margin 8.8%FY2020 net margin 9.4%FY2021 net margin 10.6%FY2022 net margin −24.2%FY2023 net margin 25.6%FY2024 net margin −6.1%FY2025 net margin −8.5% FY2016FY2025
Revenue$11.2B Growth+5.7% Net margin−8.5%
DGXQuest Diagnostics
FY2016 revenue $7.2BFY2017 revenue $7.4BFY2018 revenue $7.5BFY2019 revenue $7.7BFY2020 revenue $9.4BFY2021 revenue $10.8BFY2022 revenue $9.9BFY2023 revenue $9.3BFY2024 revenue $9.9BFY2025 revenue $11.0B FY2016 net margin 8.9%FY2017 net margin 10.4%FY2018 net margin 9.8%FY2019 net margin 11.1%FY2020 net margin 15.2%FY2021 net margin 18.5%FY2022 net margin 9.6%FY2023 net margin 9.2%FY2024 net margin 8.8%FY2025 net margin 9.0% FY2016FY2025
Revenue$11.0B Growth+11.8% Net margin9.0%
BIIBBiogen
FY2016 revenue $11.4BFY2017 revenue $12.3BFY2018 revenue $13.5BFY2019 revenue $14.4BFY2020 revenue $13.4BFY2021 revenue $11.0BFY2022 revenue $10.2BFY2023 revenue $9.8BFY2024 revenue $9.7BFY2025 revenue $9.9B FY2016 net margin 32.3%FY2017 net margin 20.7%FY2018 net margin 32.9%FY2019 net margin 41.0%FY2020 net margin 29.8%FY2021 net margin 14.2%FY2022 net margin 29.9%FY2023 net margin 11.8%FY2024 net margin 16.9%FY2025 net margin 13.1% FY2016FY2025
Revenue$9.9B Growth+2.2% Net margin13.1%
ZTSZoetis
FY2016 revenue $4.9BFY2017 revenue $5.3BFY2018 revenue $5.8BFY2019 revenue $6.3BFY2020 revenue $6.7BFY2021 revenue $7.8BFY2022 revenue $8.1BFY2023 revenue $8.5BFY2024 revenue $9.3BFY2025 revenue $9.5B FY2016 net margin 16.8%FY2017 net margin 16.3%FY2018 net margin 24.5%FY2019 net margin 24.0%FY2020 net margin 24.5%FY2021 net margin 26.2%FY2022 net margin 26.2%FY2023 net margin 27.4%FY2024 net margin 26.9%FY2025 net margin 28.2% FY2016FY2025
Revenue$9.5B Growth+2.3% Net margin28.2%
VRTXVertex Pharmaceuticals
FY2016 revenue $1.7BFY2017 revenue $2.5BFY2018 revenue $3.0BFY2019 revenue $4.2BFY2020 revenue $6.2BFY2021 revenue $7.6BFY2022 revenue $8.9BFY2023 revenue $9.9BFY2024 revenue $11.0BFY2025 revenue $12.0B FY2016 net margin −6.6%FY2017 net margin 10.6%FY2018 net margin 68.8%FY2019 net margin 28.3%FY2020 net margin 43.7%FY2021 net margin 30.9%FY2022 net margin 37.2%FY2023 net margin 36.7%FY2024 net margin −4.9%FY2025 net margin 32.9% FY2016FY2025
Revenue$12.0B Growth+8.9% Net margin32.9%
ZBHZimmer Biomet
FY2016 revenue $7.7BFY2017 revenue $7.8BFY2018 revenue $7.9BFY2019 revenue $8.0BFY2020 revenue $6.1BFY2021 revenue $6.8BFY2022 revenue $6.9BFY2023 revenue $7.4BFY2024 revenue $7.7BFY2025 revenue $8.2B FY2016 net margin 4.0%FY2017 net margin 23.2%FY2018 net margin −4.8%FY2019 net margin 14.2%FY2020 net margin −2.3%FY2021 net margin 5.9%FY2022 net margin 3.3%FY2023 net margin 13.8%FY2024 net margin 11.8%FY2025 net margin 8.6% FY2016FY2025
Revenue$8.2B Growth+7.2% Net margin8.6%
HSICHenry Schein
FY2016 revenue $11.6BFY2017 revenue $8.9BFY2018 revenue $9.4BFY2019 revenue $10.0BFY2020 revenue $10.1BFY2021 revenue $12.4BFY2022 revenue $12.6BFY2023 revenue $12.3BFY2024 revenue $12.7BFY2025 revenue $13.2B FY2016 net margin 4.4%FY2017 net margin 4.6%FY2018 net margin 5.7%FY2019 net margin 7.0%FY2020 net margin 4.0%FY2021 net margin 5.1%FY2022 net margin 4.3%FY2023 net margin 3.4%FY2024 net margin 3.1%FY2025 net margin 3.0% FY2016FY2025
Revenue$13.2B Growth+4.0% Net margin3.0%
SOLVSolventum
FY2022 revenue $8.1BFY2023 revenue $8.2BFY2024 revenue $8.3BFY2025 revenue $8.3B FY2022 net margin 16.5%FY2023 net margin 16.4%FY2024 net margin 5.8%FY2025 net margin 18.7% FY2016FY2025
Revenue$8.3B Growth+0.9% Net margin18.7%

Who rewrote the most

Share of the words changed in Risk Factors and in MD&A, latest 10-K against the one before

Risk FactorsMD&AEach company's latest 10-K, so the dates differ. A company that rewrote much may have reorganized the text.

Revenue, FY2016 to FY2025

Revenue as reported in the 10-K.

100 200 500 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ISRG: $2.7B, $3.1B, $3.7B, $4.5B, $4.4B, $5.7B, $6.2B, $7.1B, $8.4B, $10.1B ISRG BAX: $10.2B, $10.6B, $11.1B, $11.4B, $11.7B, $12.1B, $10.1B, $10.4B, $10.6B, $11.2B BAX DGX: $7.2B, $7.4B, $7.5B, $7.7B, $9.4B, $10.8B, $9.9B, $9.3B, $9.9B, $11.0B DGX BIIB: $11.4B, $12.3B, $13.5B, $14.4B, $13.4B, $11.0B, $10.2B, $9.8B, $9.7B, $9.9B BIIB ZTS: $4.9B, $5.3B, $5.8B, $6.3B, $6.7B, $7.8B, $8.1B, $8.5B, $9.3B, $9.5B ZTS VRTX: $1.7B, $2.5B, $3.0B, $4.2B, $6.2B, $7.6B, $8.9B, $9.9B, $11.0B, $12.0B VRTX ZBH: $7.7B, $7.8B, $7.9B, $8.0B, $6.1B, $6.8B, $6.9B, $7.4B, $7.7B, $8.2B ZBH HSIC: $11.6B, $8.9B, $9.4B, $10.0B, $10.1B, $12.4B, $12.6B, $12.3B, $12.7B, $13.2B HSIC SOLV: -, -, -, -, -, -, $8.1B, $8.2B, $8.3B, $8.3B SOLV BHC: $9.7B, $8.7B, $8.4B, $8.6B, $8.0B, $8.4B, $8.1B, $8.8B, $9.6B, $10.3B BHC
BHC is the bold green line; each peer has its own colour and dash, named at the line's end. Each company's first year in the window is 100, on a log scale: a line twice as high has doubled. A gap is a year with no number. A ring marks where a line starts: SOLV has no earlier 10-K here. BAX, ZBH: the line is cut where a later 10-K restates the year before (a spin-off or a merger), so the two years are not the same company.

Sales growth, FY2016 to FY2025

Revenue against the fiscal year before.

−18.3% +64.9% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ISRG: +13.4%, +16.0%, +18.7%, +20.3%, −2.7%, +31.0%, +9.0%, +14.5%, +17.2%, +20.5% ISRG BAX: +2.0%, +3.9%, +4.9%, +2.4%, +2.7%, +9.5%, +19.4%, +3.0%, +2.7%, +5.7% BAX DGX: +0.3%, +2.6%, +1.7%, +2.6%, +22.1%, +14.3%, −8.4%, −6.4%, +6.7%, +11.8% DGX BIIB: +6.4%, +7.2%, +9.6%, +6.9%, −6.5%, −18.3%, −7.4%, −3.3%, −1.6%, +2.2% BIIB ZTS: +2.6%, +8.6%, +9.8%, +7.5%, +6.6%, +16.5%, +3.9%, +5.7%, +8.3%, +2.3% ZTS VRTX: +64.9%, +46.2%, +22.5%, +36.6%, +49.1%, +22.1%, +17.9%, +10.5%, +11.7%, +8.9% VRTX ZBH: +27.9%, +1.8%, +1.7%, +0.6%, −12.0%, +11.4%, +1.6%, +6.5%, +3.8%, +7.2% ZBH HSIC: +8.9%, +7.7%, +6.0%, +6.0%, +1.3%, +22.6%, +2.0%, −2.4%, +2.7%, +4.0% HSIC SOLV: -, -, -, -, -, -, -, +0.8%, +0.7%, +0.9% SOLV BHC: −7.4%, −9.8%, −3.9%, +2.6%, −6.7%, +5.1%, −3.7%, +7.8%, +9.9%, +6.7% BHC
BHC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −18.3% to +64.9%. A gap is a year with no number. A ring marks where a line starts: SOLV has no earlier 10-K here.

Gross margin, FY2016 to FY2025

Gross profit / revenue.

27.8% 87.1% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ISRG: 69.9%, 70.2%, 69.9%, 69.4%, 65.6%, 69.3%, 67.4%, 66.4%, 67.5%, 66.0% ISRG BAX: 40.5%, 42.3%, 42.9%, 41.9%, 39.3%, 38.9%, 35.3%, 40.1%, 37.5%, 30.1% BAX DGX: 40.2%, 36.2%, 34.6%, 34.8%, 38.5%, -, -, -, -, - DGX BIIB: 87.1%, 86.7%, 86.5%, 86.4%, 86.6%, -, -, -, -, - BIIB HSIC: 27.9%, 30.9%, 30.9%, 31.0%, 27.8%, 29.6%, 30.3%, 31.3%, 31.7%, 31.1% HSIC SOLV: -, -, -, -, -, -, 57.7%, 57.3%, 55.6%, 53.5% SOLV
BHC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 27.8% to 87.1%. A gap is a year with no number. A ring marks where a line starts: SOLV has no earlier 10-K here.
CompanyFY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
BHC Dec ----------
ISRG Dec 69.9%70.2%69.9%69.4%65.6%69.3%67.4%66.4%67.5%66.0%
BAX Dec 40.5%42.3%42.9%41.9%39.3%38.9%35.3%40.1%37.5%30.1%
DGX Dec 40.2%36.2%34.6%34.8%38.5%-----
BIIB Dec 87.1%86.7%86.5%86.4%86.6%-----
ZTS Dec ----------
VRTX Dec ----------
ZBH Dec ----------
HSIC Dec 27.9%30.9%30.9%31.0%27.8%29.6%30.3%31.3%31.7%31.1%
SOLV Dec ------57.7%57.3%55.6%53.5%
Peer median40.5%42.3%42.9%41.9%39.3%38.9%46.5%48.7%46.6%42.3%

Operating margin, FY2016 to FY2025

Operating income / revenue.

−28.4% 49.0% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ISRG: 35.1%, 33.9%, 32.2%, 30.7%, 24.1%, 31.9%, 25.3%, 24.8%, 28.1%, 29.3% ISRG BAX: 7.3%, 12.2%, 14.3%, 15.6%, 13.8%, 11.1%, −28.3%, 6.8%, 0.1%, −2.7% BAX DGX: 17.7%, 15.7%, 14.6%, 15.9%, 20.9%, 22.1%, 14.4%, 13.6%, 13.6%, 14.1% DGX BIIB: 45.0%, 43.6%, 43.8%, 49.0%, 33.8%, 25.9%, -, -, -, - BIIB VRTX: 0.6%, 5.0%, 20.8%, 28.8%, 46.0%, 36.7%, 48.2%, 38.8%, −2.1%, 34.8% VRTX ZBH: 10.7%, 10.2%, 0.4%, 14.3%, 1.4%, 12.6%, 10.0%, 17.3%, 16.7%, 13.3% ZBH HSIC: 6.7%, 7.5%, 6.4%, 7.2%, 5.3%, 6.9%, 5.9%, 5.0%, 4.9%, 5.0% HSIC SOLV: -, -, -, -, -, -, 20.8%, 20.6%, 12.6%, 26.2% SOLV BHC: −5.9%, 1.2%, −28.4%, −2.4%, 8.4%, 5.3%, 5.6%, 11.0%, 16.1%, 17.7% BHC
BHC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −28.4% to 49.0%. A gap is a year with no number. A ring marks where a line starts: SOLV has no earlier 10-K here.

Net margin, FY2016 to FY2025

Net income / revenue.

−49.5% 68.8% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ISRG: 27.3%, 21.4%, 30.3%, 30.8%, 24.3%, 29.9%, 21.3%, 25.2%, 27.8%, 28.4% ISRG BAX: 48.9%, 5.7%, 13.9%, 8.8%, 9.4%, 10.6%, −24.2%, 25.6%, −6.1%, −8.5% BAX DGX: 8.9%, 10.4%, 9.8%, 11.1%, 15.2%, 18.5%, 9.6%, 9.2%, 8.8%, 9.0% DGX BIIB: 32.3%, 20.7%, 32.9%, 41.0%, 29.8%, 14.2%, 29.9%, 11.8%, 16.9%, 13.1% BIIB ZTS: 16.8%, 16.3%, 24.5%, 24.0%, 24.5%, 26.2%, 26.2%, 27.4%, 26.9%, 28.2% ZTS VRTX: −6.6%, 10.6%, 68.8%, 28.3%, 43.7%, 30.9%, 37.2%, 36.7%, −4.9%, 32.9% VRTX ZBH: 4.0%, 23.2%, −4.8%, 14.2%, −2.3%, 5.9%, 3.3%, 13.8%, 11.8%, 8.6% ZBH HSIC: 4.4%, 4.6%, 5.7%, 7.0%, 4.0%, 5.1%, 4.3%, 3.4%, 3.1%, 3.0% HSIC SOLV: -, -, -, -, -, -, 16.5%, 16.4%, 5.8%, 18.7% SOLV BHC: −24.9%, 27.6%, −49.5%, −20.8%, −7.0%, −11.2%, −2.8%, −6.8%, −0.5%, 1.5% BHC
BHC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −49.5% to 68.8%. A gap is a year with no number. A ring marks where a line starts: SOLV has no earlier 10-K here.

Free cash flow, FY2016 to FY2025

Cash from operations minus capital spending.

−$946.0M $6.6B FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ISRG: $1.0B, $953.2M, $982.2M, $1.2B, $1.1B, $1.7B, $958.4M, $749.6M, $1.3B, $2.5B ISRG BAX: $935.0M, $1.1B, $1.4B, $1.4B, $1.2B, $1.5B, $834.0M, $1.3B, $573.0M, $332.0M BAX DGX: $823.0M, $923.0M, $817.0M, $843.0M, $1.6B, $1.8B, $1.3B, $864.0M, $909.0M, $1.4B DGX BIIB: $4.0B, $3.7B, $5.4B, $6.6B, $3.8B, $3.4B, $1.1B, $1.3B, $2.7B, $2.1B BIIB ZTS: $497.0M, $1.1B, $1.5B, $1.3B, $1.7B, $1.7B, $1.3B, $1.6B, $2.3B, $2.3B ZTS VRTX: $179.5M, $745.5M, $1.2B, $1.5B, $3.0B, $2.4B, $3.9B, $3.3B, −$790.3M, $3.2B VRTX ZBH: $1.4B, $1.4B, $1.6B, $1.4B, $1.1B, $1.4B, $1.2B, $1.3B, $1.3B, $1.5B ZBH HSIC: $572.4M, $483.1M, $613.4M, $577.9M, $550.0M, $631.0M, $506.0M, $353.0M, $700.0M, $573.0M HSIC SOLV: -, -, -, -, -, -, $1.4B, $1.6B, $805.0M, −$10.0M SOLV BHC: $1.9B, $2.1B, $1.3B, $1.2B, $809.0M, $1.2B, −$946.0M, $817.0M, $1.3B, $1.0B BHC
BHC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$946.0M to $6.6B. A gap is a year with no number. A ring marks where a line starts: SOLV has no earlier 10-K here.

FCF margin, FY2016 to FY2025

Free cash flow / revenue.

−11.6% 48.2% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ISRG: 38.2%, 30.4%, 26.4%, 26.2%, 26.2%, 30.6%, 15.4%, 10.5%, 15.6%, 24.7% ISRG BAX: 9.2%, 10.4%, 12.2%, 12.4%, 9.9%, 12.6%, 8.3%, 12.5%, 5.4%, 3.0% BAX DGX: 11.4%, 12.5%, 10.8%, 10.9%, 16.8%, 17.0%, 13.3%, 9.3%, 9.2%, 12.3% DGX BIIB: 34.7%, 30.0%, 40.3%, 45.7%, 28.3%, 30.8%, 11.2%, 12.9%, 28.1%, 20.7% BIIB ZTS: 10.2%, 21.1%, 24.9%, 21.3%, 25.1%, 22.3%, 16.4%, 19.0%, 24.8%, 24.1% ZTS VRTX: 10.5%, 30.0%, 38.5%, 35.9%, 48.2%, 31.8%, 44.0%, 33.8%, −7.2%, 26.6% VRTX ZBH: 18.9%, 18.3%, 20.0%, 17.3%, 17.8%, 19.9%, 16.8%, 17.5%, 16.9%, 17.9% ZBH HSIC: 4.9%, 5.4%, 6.5%, 5.8%, 5.4%, 5.1%, 4.0%, 2.9%, 5.5%, 4.3% HSIC SOLV: -, -, -, -, -, -, 17.6%, 19.8%, 9.8%, −0.1% SOLV BHC: 19.1%, 24.3%, 16.0%, 14.3%, 10.1%, 13.7%, −11.6%, 9.3%, 13.1%, 9.8% BHC
BHC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −11.6% to 48.2%. A gap is a year with no number. A ring marks where a line starts: SOLV has no earlier 10-K here.

Return on equity, FY2016 to FY2025

Net income / shareholders' equity at the year end.

−168.2% 78.3% FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ISRG: 12.8%, 14.0%, 16.9%, 16.7%, 10.9%, 14.3%, 12.0%, 13.5%, 14.1%, 16.0% ISRG BAX: 59.9%, 6.6%, 19.7%, 12.7%, 12.7%, 14.1%, −41.7%, 31.6%, −9.3%, −15.6% BAX DGX: 13.9%, 15.7%, 14.1%, 15.2%, 21.2%, 31.0%, 16.1%, 13.5%, 12.9%, 13.8% DGX BIIB: 30.5%, 20.1%, 34.0%, 44.1%, 37.4%, 14.3%, 22.7%, 7.8%, 9.8%, 7.1% BIIB ZTS: 55.2%, 48.8%, 65.4%, 55.4%, 43.5%, 44.8%, 48.0%, 46.9%, 52.1%, 78.3% ZTS VRTX: −9.7%, 13.0%, 47.3%, 19.3%, 31.2%, 23.2%, 23.9%, 20.6%, −3.3%, 21.2% VRTX ZBH: 3.2%, 15.5%, −3.4%, 9.1%, −1.1%, 3.2%, 1.9%, 8.2%, 7.2%, 5.6% ZBH HSIC: 18.1%, 14.5%, 18.1%, 23.2%, 12.1%, 18.4%, 15.6%, 11.4%, 11.5%, 12.3% HSIC SOLV: -, -, -, -, -, -, 11.4%, 11.5%, 16.2%, 30.8% SOLV BHC: −76.4%, 41.1%, −151.8%, −168.2%, −104.7%, n/m, n/m, n/m, n/m, n/m BHC
BHC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −168.2% to 78.3%. A gap is a year with no number. A ring marks where a line starts: SOLV has no earlier 10-K here.

Debt / equity, FY2016 to FY2025

Total debt / shareholders' equity at the year end.

0.00 9.47 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 BAX: 0.34, 0.38, 0.44, 0.68, 0.72, 1.99, 2.91, 1.65, 2.20, 1.54 BAX DGX: 0.81, 0.77, 0.75, 0.85, 0.59, 0.62, 0.68, 0.75, 0.92, 0.79 DGX BIIB: 0.54, 0.47, 0.46, 0.33, 0.69, 0.58, 0.47, 0.46, 0.27, 0.34 BIIB ZTS: 3.00, 2.80, 2.95, 2.38, 1.91, 1.45, 1.79, 1.31, 1.38, 2.65 ZTS VRTX: -, -, -, -, -, -, -, -, -, 0.00 VRTX ZBH: 1.16, 0.86, 0.79, 0.66, 0.67, 0.08, 0.47, 0.46, 0.50, 0.59 ZBH HSIC: 0.28, 0.33, 0.66, 0.25, 0.21, 0.25, 0.33, 0.64, 0.75, 0.96 HSIC SOLV: -, -, -, -, -, -, -, 0.00, 2.71, 1.00 SOLV BHC: 9.47, 4.35, 8.89, n/m, n/m, n/m, n/m, n/m, n/m, n/m BHC
BHC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from 0.00 to 9.47. A gap is a year with no number. A ring marks where a line starts: VRTX, SOLV have no earlier 10-K here.

EPS (diluted), FY2016 to FY2025

Diluted earnings per share, on today's share count after splits.

−$11.81 $31.42 FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025 ISRG: $2.09, $1.92, $3.16, $3.85, $2.94, $4.66, $3.65, $5.03, $6.42, $7.87 ISRG BAX: $9.01, $1.08, $2.83, $1.93, $2.13, $2.53, −$4.83, $5.23, −$1.27, −$1.87 BAX DGX: $4.51, $5.50, $5.29, $6.28, $10.47, $15.55, $7.97, $7.49, $7.69, $8.75 DGX BIIB: $16.93, $11.92, $21.58, $31.42, $24.80, $10.40, $20.87, $7.97, $11.18, $8.79 BIIB ZTS: $1.65, $1.75, $2.93, $3.11, $3.42, $4.27, $4.49, $5.07, $5.47, $6.02 ZTS VRTX: −$0.46, $1.04, $8.09, $4.51, $10.29, $9.01, $12.82, $13.89, −$2.08, $15.32 VRTX ZBH: $1.51, $8.90, −$1.86, $5.47, −$0.67, $1.91, $1.10, $4.88, $4.43, $3.55 ZBH HSIC: $3.10, $2.57, $3.49, $4.65, $2.82, $4.45, $3.91, $3.16, $3.05, $3.27 HSIC SOLV: -, -, -, -, -, -, $7.78, $7.79, $2.76, $8.88 SOLV BHC: −$6.94, $6.83, −$11.81, −$5.08, −$1.58, −$2.64, −$0.62, −$1.62, −$0.13, $0.42 BHC
BHC is the bold green line; each peer has its own colour and dash, named at the line's end. One scale from −$11.81 to $31.42. A gap is a year with no number. A ring marks where a line starts: SOLV has no earlier 10-K here.

Fiscal years are lined up as each company's 10-K names them; the month next to a ticker is when its year ends. Hover a number for the XBRL line items and the filing; click it to open the filing on sec.gov. "n/m" means not meaningful: equity below zero, or a base so close to zero that the ratio says nothing. The peer median leaves out BHC and needs at least three peers with the number. P/E, P/S and P/FCF at each year end appear here once the site has daily prices. What the same companies write about AI, tariffs and more

Sources

Each company's 10-K, from SEC's XBRL company facts. Every number links to its filing in the Inline XBRL viewer.

Also

Financials: BHC's own statements, year by year. Compare: the whole peer group on one page.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/BHC/export.csv") into a cell.

Next:Industry numbers
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.